Interferon Beta-1a for Multiple Sclerosis
Interferon Beta-1a is a recombinant human protein used to manage relapsing multiple sclerosis. It is produced through biotechnological processes and acts as an immunological product that regulates immune responses. This places it under tariff item 3002.90.00, which covers other blood fractions and immunological products.
Import Duty Rates by Country of Origin
| Origin Country | MFN Tariff | Surtaxes | Total Effective Rate |
|---|---|---|---|
| 🇨🇳China | Free | — | Free |
| 🇲🇽Mexico | Free | — | Free |
| 🇺🇸United States | Free | — | Free |
| 🇩🇪Germany | Free | — | Free |
| 🇯🇵Japan | Free | — | Free |
More Specific Codes
This product may fall under a more specific subheading:
Alternative Classifications
This product could be classified differently depending on its characteristics or intended use.
If packaged in measured doses for retail sale
Medicaments put up in measured doses fall under heading 30.04 rather than 30.02.
If presented as a specific immunological product for therapeutic use
Subheading 3002.15 covers immunological products put up in measured doses or for retail sale.
Not sure which classification is right?
The Tariff Assistant works through the GRI rules on your specific product to reach the right tariff item — and can price the duty on it in the same conversation.
Import Tips & Compliance
• Ensure the product is accompanied by a valid Drug Identification Number (DIN) from Health Canada
• Declare the biological nature of the product to the CBSA to avoid delays
• Keep records of the biotechnological production process to support classification
Related Products under Tariff item 3002.90.00
Anticoagulated Whole Human Blood Units
Anticoagulated whole human blood units are collected from donors and treated with CPD or CPDA-1 to prevent clotting. These units are stored in PVC bags for emergency transfusions. As unmodified whole human blood for therapeutic use, they fall under tariff item 3002.90.00.
Anti-Hemophilic Factor VIII Concentrate
A lyophilized concentrate of coagulation Factor VIII derived from human plasma, used therapeutically for hemophilia A treatment. As a blood fraction prepared for therapeutic uses, it falls under tariff item 3002.90.00 as 'Other' within the heading for human blood and immunological products.
Aspergillopepsin Antifungal Ferment
Purified aspergillopepsin ferment derived from Aspergillus molds, formulated for therapeutic antifungal applications in human patients. This product is a microbial culture-derived ferment prepared for therapeutic use, excluding yeasts, and falls under tariff item 3002.90.00 as 'Other' within the heading for immunological products and similar goods.
Azelastine Hydrochloride Nasal Spray
Azelastine hydrochloride nasal spray is an antihistamine used to relieve seasonal allergic rhinitis. It is an antiallergenic preparation that targets nasal mucosa allergies. Despite its therapeutic use, it is not an immunological product and is incorrectly listed under this tariff item.
Bepotastine Besilate Eye Drops
Bepotastine besilate eye drops are a topical antihistamine for ocular allergies and conjunctivitis. They are antiallergenic preparations targeting eye-specific histamine blockade. These are not immunological products and should not be classified under tariff item 3002.90.00.
Bilastine 20mg Tablets
Bilastine 20mg tablets are a non-sedating antihistamine for allergic rhinitis and urticaria. They require food co-administration for absorption. As an antiallergenic preparation, they are not immunological products and are incorrectly listed under tariff item 3002.90.00.